Mesoblast (MESO) Receivables - Other (2017 - 2024)
Mesoblast (MESO) posted quarterly Receivables - Other of $18.0 million for Q4 2024, up 498.53% year-on-year from $3.0 million in Q1 2024, and up 498.53% on a QoQ basis from $3.0 million in Q4 2023.
Mesoblast (MESO) Receivables - Other (2017 - 2024) Analysis & Trends
Mesoblast (MESO) has reported Receivables - Other for 6 consecutive years, with $18.0 million the latest figure, recorded in Q4 2024.
- Quarterly Receivables - Other rose 498.53% year-over-year to $18.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $18.0 million (up 498.53% YoY) and the FY2019 annual result came in at $1.5 million, up 143.9% from the prior year.
- Receivables - Other grew to $18.0 million in Q4 2024 per MESO's latest filing, from $3.0 million in the prior quarter.
- Over the last five years, Receivables - Other for MESO reached as high as $18.0 million in Q4 2024 and fell as low as $894000.0 in Q4 2022.
- A 3-year average of $5.7 million and a median of $2.0 million in 2023 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2023 — Receivables - Other jumped 235.57% — and 2024, when it soared 498.53%.
- Year by year, Receivables - Other stood at $894000.0 in 2022, then soared by 235.57% to $3.0 million in 2023, then surged by 498.53% to $18.0 million in 2024.
- According to Business Quant data, Receivables - Other over the past three periods registered $18.0 million, $3.0 million, and $1.0 million for Q4 2024, Q4 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 17.96 Mn |
| Dec 31, 2024 | 17.96 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 894,000.00 |
| Dec 31, 2022 | 894,000.00 |
| Jun 30, 2019 | 1.50 Mn |
| Jun 30, 2019 | 1.50 Mn |
| Mar 31, 2019 | 134,000.00 |
| Mar 31, 2019 | 134,000.00 |
| Dec 31, 2018 | 93,000.00 |
| Dec 31, 2018 | 93,000.00 |
| Sep 30, 2018 | 242,000.00 |
| Sep 30, 2018 | 242,000.00 |
| Jun 30, 2018 | 615,000.00 |
| Jun 30, 2018 | 615,000.00 |
| Mar 31, 2018 | 1.01 Mn |
| Mar 31, 2018 | 1.01 Mn |